TIDMSN.

RNS Number : 2632E

Smith & Nephew Plc

09 March 2022

SMITH & NEPHEW PLC

9 March 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

   1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010 AND 2020 

On 7 March 2022, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010 and 2020.

i. FINAL VESTING ON 7 MARCH 2022 OF 2019 EQUITY INCENTIVE PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

The awards were granted under the Global Share Plan 2010 on 7 March 2019. One third of the Shares vested on 7 March 2020, a further third vested on 7 March 2021 and the final third vested on 7 March 2022. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards. The number of Shares acquired includes the dividend equivalent Shares which participants receive on vested Shares.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            -------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            -------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            -------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            -------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            -------------------------------------------- 
 Nature of the transaction   Final vesting of Equity Incentive Programme 
                              awards granted on 7 March 2019 under 
                              the Smith & Nephew Global Share Plan 
                              2010. 
                            -------------------------------------------- 
 Date of Transaction         2022 - 03 - 07 
                            -------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            -------------------------------------------- 
 
 
                                                                                                      Total Ordinary 
                                                                                                       Share Holding 
                                                                                 Total Ordinary        as a % of 
                                                                                  Share Holding        the Company's 
                                                                                  following            ISC following 
 Name                                                             Aggregated      the transaction      the transaction 
  (Position)             Status    Price (GBP)   Volume            information    *                    * 
                                                 2,417 
                                                  (of which 
                                                  1,140 
 Helen Barraclough                                were sold                      18,769.75378 
  (Group General                                  and 1,277       N/A Single      ordinary 
  Counsel)             PDMR        12.011211      retained)        Transaction    shares              0.00212% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
 Bradley Cannon                                  4,983 
  (President,                                     (of which                      81,825.17832 
  Orthopaedics,                                   1,688                           ordinary 
  Sports Medicine                                 were sold                       shares (including 
  & ENT and                                       and 3,295       N/A Single      2,718.50860 
  Americas)            PDMR        12.011211      retained)        Transaction    in ADS')            0.00924% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
                                                 2,486 
 Phil Cowdy                                       (of which 
  (Chief Business                                 1,173 
  Development                                     were sold                      48,446.96621 
  & Corporate                                     and 1,313       N/A Single      ordinary 
  Affairs Officer)     PDMR        12.011211      retained)        Transaction    shares              0.00547% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
                                                 4,724 
                                                  (of which                      109,689.00000 
                                                  1,851                           ordinary 
 Elga Lohler                                      were sold                       shares (including 
  (Chief HR                                       and 2,873       N/A Single      3,015.00000 
  Officer)             PDMR        12.011211      retained)        Transaction    in ADS')            0.01239% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
                                                 4,274 
                                                  (of which 
 Vasant Padmanabhan                               1,587 
  (President                                      were sold                      67307.00000 
  Research                                        and 2,687       N/A Single      ordinary 
  & Development)       PDMR        12.011211      retained)        Transaction    shares              0.00760% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
                                                 1,743 
                                                  (of which 
 Susan Swabey                                     823 were                       50,970.39347 
  (Company                                        sold and        N/A Single      ordinary 
  Secretary)           PDMR        12.011211      920 retained)    Transaction    shares              0.00576% 
                      ----------  ------------  ---------------  -------------  -------------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

ii. FINAL VESTING ON 7 MARCH 2022 OF SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2019 PERFORMANCE SHARE PROGRAMME AWARDS:

The awards were granted under the Global Share Plan 2020 on 8 March 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------- 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of 
  financial instrument,       USD 0.20 each 
  type of instrument 
                            ------------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------------- 
 Nature of the transaction   Final vesting on 7 March 2022 of Supplementary 
                              Awards granted under the Smith & Nephew 
                              Global Share Plan 2020 for the 2019 Performance 
                              Share Programme awards . 
                            ------------------------------------------------- 
 Date of Transaction         2022 - 03 - 07 
                            ------------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------------- 
 
 
                                                                                                  Total Ordinary 
                                                                                                   Share Holding 
                                                                             Total Ordinary        as a % of 
                                                                              Share Holding        the Company's 
                                                                              following            ISC following 
 Name                                                         Aggregated      the transaction      the transaction 
  (Position)             Status    Price (GBP)   Volume        information    *                    * 
                                                 3,013 
                                                  (of which 
                                                  1,422 
 Helen Barraclough                                were sold                  20,360.75378 
  (Group General                                  and 1,591   N/A Single      ordinary 
  Counsel)             PDMR        12.011211      retained)    Transaction    shares              0.00230% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
 Bradley Cannon                                  7,696 
  (President,                                     (of which                  86,914.17832 
  Orthopaedics,                                   2,607                       ordinary 
  Sports Medicine                                 were sold                   shares (including 
  & ENT and                                       and 5,089   N/A Single      2,718.50860 
  Americas)            PDMR        12.011211      retained)    Transaction    in ADS')            0.00982% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
                                                 5,641 
 Phil Cowdy                                       (of which 
  (Chief Business                                 2,661 
  Development                                     were sold                  51,426.96621 
  & Corporate                                     and 2,980   N/A Single      ordinary 
  Affairs Officer)     PDMR        12.011211      retained)    Transaction    shares              0.00581% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
 Simon Fraser 
  (President,                                    6,791 
  Advanced                                        (of which 
  Wound Management                                2,021 
  & Global                                        were sold                  15,433.59428 
  Commercial                                      and 4,770   N/A Single      ordinary 
  Operations)          PDMR        12.011211      retained)    Transaction    shares              0.00174% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
                                                 6,680 
                                                  (of which                  113,743.00000 
                                                  2,626                       ordinary 
 Elga Lohler                                      were sold                   shares (including 
  (Chief HR                                       and 4,054   N/A Single      3,015.00000 
  Officer)             PDMR        12.011211      retained)    Transaction    in ADS')            0.01285% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
                                                 6,595 
                                                  (of which 
 Vasant Padmanabhan                               2,449 
  (President                                      were sold                  71,453.00000 
  Research                                        and 4,146   N/A Single      ordinary 
  & Development)       PDMR        12.011211      retained)    Transaction    shares              0.00807% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
                                                 2,446 
                                                  (of which 
                                                  1,154 
 Susan Swabey                                     were sold                  52,262.39347 
  (Company                                        and 1,292   N/A Single      ordinary 
  Secretary)           PDMR        12.011211      retained)    Transaction    shares              0.00590% 
                      ----------  ------------  -----------  -------------  -------------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

   2.   PHIL COWDY - SALE OF ORDINARY SHARES 
 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------ 
 Details of the transaction(s): section to be repeated for (i) 
  each type of instrument; (ii) each type of transaction; (iii) 
  each date; and (iv) each place where transactions have been 
  conducted 
 Description of the          Smith & Nephew plc ordinary shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------ 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------ 
 Nature of the transaction   Sale of ordinary shares. 
                            ------------------------------------------ 
 Date of Transaction         2022 - 03 - 08 
                            ------------------------------------------ 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------ 
 
 
                                                                                           Total Ordinary 
                                                                                            Share Holding 
                                                                        Total Ordinary      as a % of 
                                                                         Share Holding      the Company's 
                                                                         following          ISC following 
                      Director                           Aggregated      the transaction    the transaction 
 Name (Position)       / PDMR     Price (GBP)   Volume    information    *                  * 
 Phil Cowdy 
  (Chief Business 
  Development                                                           47,133.96621 
  & Corporate                                            N/A Single      ordinary 
  Affairs Officer)    PDMR        11.793781     4,293     Transaction    shares            0.00532% 
                     ----------  ------------  -------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFEDVAIAIIF

(END) Dow Jones Newswires

March 09, 2022 13:01 ET (18:01 GMT)

Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Smith & Nephew
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Smith & Nephew